CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
Usama Khamis Hussein(Beni-Suef University), Kyu Yun Jang(Jeonbuk National University Hospital)
Cited by 16
Related Papers
SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas
|PLoS ONE|2012|109
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
|Journal of Experimental & Clinical Cancer Research|2018|96
CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients
|American Journal Of Pathology|2016|89
Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas
|PLoS ONE|2013|60
SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
|Frontiers in Oncology|2018|50